Tag: Vivoryon

April 1, 2022 Off

Vivoryon Therapeutics Completes Private Placement Raising EUR 21M

By Author

Vivoryon Therapeutics N.V. has completed a private placement by way of accelerated bookbuilding, placing 2,000,000 registered shares at an offering price of EUR 10.50 per share.

February 28, 2022 Off

Vivoryon Therapeutics and Simcere Announce CDE Approval of Chinese Clinical Trial Application for Varoglutamstat in Patients with Alzheimer’s Disease

By Dino Mustafić

Vivoryon Therapeutics a clinical-stage biotechnology company focused on developing innovative small molecule-based medicines and Simcere Pharmaceutical Group have announced that…